Effect of Photodynamic Therapy on Gingival Crevicular Cytokines in Periodontitis Patients

February 26, 2018 updated by: Foo Lean Heong, National University, Singapore
Systemically healthy periodontitis patients were recruited in this single-blind, split-mouth, randomized controlled clinical trial. After SRP, PDT was applied at probing depth (PD) ≥ 4 mm at test quadrant. At baseline, 3rd month and 6th month, clinical parameters and cytokine pattern in gingival crevicular fluids (GCFs) were analysed.

Study Overview

Detailed Description

Periodontal parameters and cytokine IL-1β, IL-6, IL-8, TNF-α, MMP-8 levels were analysed.

Study Type

Interventional

Enrollment (Actual)

51

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adults who were medically fit or have medical condition that did not alter the outcome of periodontal treatment.
  • Females who were not pregnant or nursing.
  • Controlled diabetes mellitus with HbA1c < 7.5 mmol/L.
  • Not on any antibiotics or steroids 3 months prior to periodontal treatment.
  • Diagnosed to have either localized or generalized chronic or aggressive periodontitis (Armitage, 1999) with all 4 quadrants having at least 2 sites with probing depth ≥ 4 mm.
  • Consented to follow the non-surgical periodontal treatment (scaling and root planing) with PDT throughout the period of study, i.e. approximately 6 months.

Exclusion Criteria:

  • Allergic to photosensitizer or dye
  • Pregnant lady and nursing mothers
  • Uncontrolled diabetes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: SRP and Fotosan 630
Scaling and root planing, photodynamic therapy using Fotosan 630
After isolating the test quadrants with cotton roll, toluidine blue was applied into the deep pockets (PD ≥ 4mm) at the test quadrants for 10 seconds, followed by inserting a perio tip (15 or 21 mm depending on the depth of the pocket) that connected to a LED emitting device, and light was emitted for 20 seconds. Toluidine blue in the deep pocket was removed by injecting normal saline into the pocket.
Other Names:
  • Fotosan 630, CMS Dental, Copenhagen, Denmark
NO_INTERVENTION: Control
Scaling and root planing only

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes from baseline probing depth at 3rd month and 6th month
Time Frame: 3 months and 6 months
Clinical probing depth in mm
3 months and 6 months
Changes from baseline clinical attachment level at 3rd month and 6th month
Time Frame: 3 months and 6 months
Clinical attachment level in mm
3 months and 6 months
Changes from baseline gingival recession level at 3rd month and 6th month
Time Frame: 3 months and 6 months
Gingival recession level in mm
3 months and 6 months
Changes from baseline bleeding score at 3rd month and 6th month
Time Frame: 3 months and 6 months
Bleeding score in percentage
3 months and 6 months
Changes from baseline Interleukin-1 level at 3rd month and 6th month
Time Frame: 3 months and 6 months
Interleukin-1 level in gingival crevicular fluid
3 months and 6 months
Changes from baseline Interleukin-6 level at 3rd month and 6th month
Time Frame: 3 months and 6 months
Interlekin-6 level in gingival crevicular fluid
3 months and 6 months
Changes from baseline Interleukin-8 level at 3rd month and 6th month
Time Frame: 3 months and 6 months
Interleukin-8 level in gingival crevicular fluid
3 months and 6 months
Changes from baseline Tumour necrosis factor-alpha level at 3rd month and 6th month
Time Frame: 3 months and 6 months
Tumour necrosis factor-alpha level in gingival crevicular fluid
3 months and 6 months
Changes from baseline Matrix metalloproteinase-8 level at 3rd month and 6th month
Time Frame: 3 months and 6 months
Matrix metalloproteinase-8 level in gingival crevicular fluid
3 months and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Lum Peng Lim, Faculty of Dentistry, National University of Singapore

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2012

Primary Completion (ACTUAL)

March 31, 2013

Study Completion (ACTUAL)

June 30, 2013

Study Registration Dates

First Submitted

January 23, 2018

First Submitted That Met QC Criteria

February 26, 2018

First Posted (ACTUAL)

March 5, 2018

Study Record Updates

Last Update Posted (ACTUAL)

March 5, 2018

Last Update Submitted That Met QC Criteria

February 26, 2018

Last Verified

February 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periodontitis

Clinical Trials on SRP and Fotosan 630

3
Subscribe